On July 16, Quantinuum fell 5.11% in regular trading, trading at $57.42 per share with turnover of $21.89 million. The stock has now broken below its $60 IPO price set just over a month ago.

On the news front, the stock has been under sustained pressure since multiple top Wall Street investment banks initiated coverage on June 29 with sharply divergent valuations. Rosenblatt issued the highest target at $155, while Morgan Stanley gave the lowest at $78 with an Equal-weight rating — a near-double gap reflecting fundamental disagreement over quantum computing commercialization prospects. JPMorgan set a $97 target at Overweight, BofA Securities and Needham both initiated at Buy with $100 targets, UBS at $93, and Mizuho, Jefferies, and Cantor Fitzgerald clustered around $90.

Adding to the pressure, Quantinuum reported first-quarter revenue of just $5.24 million, a 73% year-over-year decline, with net losses ballooning to $136.5 million from $30.5 million a year earlier. The combination of wide analyst disagreement and deteriorating near-term fundamentals continues to weigh on the newly public quantum computing platform company.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)